Drug
Rose12
Rose12: highest development phase Phase 1, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| ROSE12 NCT05907980 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Rose12 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.